UPB$2.15-22.66%
Upstream Bio, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap & EV:$117.84M /
Float & O/S:43.46M / 54.81M
Est. Net Cash/Sh:
Inst Own:85.8%
DilutionScan read 37 of Upstream Bio, Inc.'s SEC filings and found 1 convertible, 1 ATM program, 1 shelf registration and 1 S-1 registration on file for UPB. The latest dilution event on file is ATM sales on Sep 30, 2026. Analysis updated Nov 15, 2026.